|
JPS60136511A
(ja)
|
1983-12-26 |
1985-07-20 |
Eisai Co Ltd |
高尿酸血症治療剤
|
|
JPS63501289A
(ja)
|
1985-09-27 |
1988-05-19 |
ザ リ−ジエンツ オブ ザ ユニバ−シテイ オブ カリフオルニア |
リポソ−ム経皮薬剤供給系
|
|
JPS6295134A
(ja)
|
1985-10-21 |
1987-05-01 |
Nippon Saafuakutanto Kogyo Kk |
リポソ−ムの製造法
|
|
US5015483A
(en)
|
1989-02-09 |
1991-05-14 |
Nabisco Brands, Inc. |
Liposome composition for the stabilization of oxidizable substances
|
|
US5498607A
(en)
|
1990-07-30 |
1996-03-12 |
University Of Miami |
Treatment for hypercholesterolemia
|
|
US6165500A
(en)
|
1990-08-24 |
2000-12-26 |
Idea Ag |
Preparation for the application of agents in mini-droplets
|
|
WO1992003122A1
(de)
|
1990-08-24 |
1992-03-05 |
Gregor Cevc |
Präparat zur wirkstoffapplikation in kleinsttröpfchenform
|
|
US5498420A
(en)
|
1991-04-12 |
1996-03-12 |
Merz & Co. Gmbh & Co. |
Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions
|
|
CA2139757C
(en)
|
1992-07-08 |
2009-04-14 |
Gunther Maierhofer |
Liposomes, method of preparing the same and use thereof in the preparation of drugs
|
|
FR2714382B1
(fr)
|
1993-12-27 |
1996-02-02 |
Roussel Uclaf |
Phospholipides vecteur de molécule active, leur préparation et leur utilisation dans des compositions cosmétiques ou dermatologiques.
|
|
DE4447287C1
(de)
|
1994-12-30 |
1996-11-07 |
Cevc Gregor |
Präparat zum Wirkstofftransport durch Barrieren
|
|
US5902604A
(en)
|
1995-06-06 |
1999-05-11 |
Board Of Regents, The University Of Texas System |
Submicron liposome suspensions obtained from preliposome lyophilizates
|
|
FR2767691B1
(fr)
|
1997-08-27 |
2000-02-18 |
Oreal |
Utilisation d'une dispersion a base de vehicules lipidiques comme composition anti-inflammatoire
|
|
US6534070B1
(en)
*
|
1997-11-19 |
2003-03-18 |
Schering Aktiengesellschaft |
Composition with azelaic acid
|
|
US6165997A
(en)
|
1997-11-20 |
2000-12-26 |
Statens Serum Institut |
Phospholipids having antimicrobial activity with or without the presence of antimicrobials
|
|
BR9816014A
(pt)
|
1998-09-01 |
2001-05-08 |
Idea Ag |
Transporte eletricamente controlado de penetrantes carregados através de barreiras
|
|
DE69825495T2
(de)
|
1998-12-23 |
2005-07-28 |
Idea Ag |
Verbesserte formulierung zur topischen, nichtinvasiven anwendung in vivo
|
|
PT1031346E
(pt)
|
1999-01-27 |
2002-09-30 |
Idea Ag |
Vacinacao nao invasiva atraves da pele
|
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
WO2001001962A1
(en)
|
1999-07-05 |
2001-01-11 |
Idea Ag. |
A method for the improvement of transport across adaptable semi-permeable barriers
|
|
US6248728B1
(en)
|
2000-03-10 |
2001-06-19 |
Kansas State University Research Foundation |
Phosphatidylcholine compositions and methods for lowering intestinal absorption and plasma levels of cholesterol
|
|
US6191121B1
(en)
*
|
2000-04-06 |
2001-02-20 |
Nicholas V. Perricone |
Treatment of skin damage using polyenylphosphatidylcholine
|
|
DE60122304T2
(de)
|
2000-04-12 |
2007-08-09 |
Liplasome Pharma A/S |
Auf lipiden basierendes system zur zielgerichteten verabreichung diagnostischer wirkstoffe
|
|
TWI281407B
(en)
|
2000-09-18 |
2007-05-21 |
Vasogen Ireland Ltd |
Apoptosis-mimicking synthetic entities and use thereof in medical treatment
|
|
US20030064948A1
(en)
|
2001-02-08 |
2003-04-03 |
Alfred Fahr |
Invasomes for therapy of disorders, their preparation and use
|
|
PL367337A1
(pl)
|
2001-05-31 |
2005-02-21 |
Pharmacia Corporation |
Przenikająca przez skórę kompozycja selektywnego inhibitora cyklooksygenazy-2
|
|
US20050123593A1
(en)
|
2001-06-25 |
2005-06-09 |
Jonathan Thompson |
Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints
|
|
CA2368656A1
(en)
|
2002-01-21 |
2003-07-21 |
Vasogen Ireland Limited |
Receptor-ligand pairing for anti-inflammatory response
|
|
AU2003233396B2
(en)
|
2002-03-13 |
2007-05-24 |
Thomas Skold |
Water-based delivery systems
|
|
US20040009180A1
(en)
|
2002-07-11 |
2004-01-15 |
Allergan, Inc. |
Transdermal botulinum toxin compositions
|
|
JP2004131432A
(ja)
|
2002-10-11 |
2004-04-30 |
Kumamoto Technology & Industry Foundation |
悪性腫瘍抑制剤
|
|
US20040105881A1
(en)
|
2002-10-11 |
2004-06-03 |
Gregor Cevc |
Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
|
|
CN1703199B
(zh)
|
2002-10-11 |
2010-04-28 |
伊迪亚股份公司 |
具有增强的可变形性、包含至少三种两亲性物质的聚集物,其用于改善通过半透屏障的转运以及非侵入性药物在体内、具体是通过皮肤的应用
|
|
JP2006525368A
(ja)
|
2003-05-02 |
2006-11-09 |
アロネックス，ファーマシューティカルズ，インコーポレーテッド |
脂質白金錯体およびその使用方法
|
|
EA200600297A1
(ru)
|
2003-07-21 |
2006-08-25 |
Васоджен Айеленд Лимитед |
Лечение острого воспалительного состояния
|
|
JP2005179313A
(ja)
|
2003-12-24 |
2005-07-07 |
Shu Uemura:Kk |
皮膚化粧料用基剤の製造方法および皮膚化粧料
|
|
US7476432B2
(en)
|
2004-05-28 |
2009-01-13 |
Tecton Products |
Phosphorescent pultrusion
|
|
CA2584475A1
(en)
|
2004-11-12 |
2006-05-18 |
Idea Ag |
Extended surface aggregates in the treatment of skin conditions
|
|
WO2006086992A2
(en)
|
2005-02-18 |
2006-08-24 |
Liplasome Pharma A/S |
Drug delivery systems containing phqspholipase a2 degradable lipid prodrug derivatives and the therapeutic uses thereof as. e.g. wound healing agents and peroxisome proliferator activated receptor ligands
|
|
US20070042008A1
(en)
|
2005-08-18 |
2007-02-22 |
Bodybio, Inc. |
Compositions containing phosphatidylcholine and essential fatty acids
|
|
UA89545C2
(uk)
|
2005-08-29 |
2010-02-10 |
Сепсикюр Л.Л.К. |
Спосіб лікування чи попередження станів, викликаних грампозитивними бактеріями
|
|
NZ569068A
(en)
|
2005-12-20 |
2011-11-25 |
Cenestra Llc |
Omega 3 fatty acid formulations of EPA and DHA
|
|
JP5009547B2
(ja)
|
2006-03-31 |
2012-08-22 |
株式会社コーセー |
顔料とリポソームを含む化粧料
|
|
US7544375B1
(en)
|
2006-06-12 |
2009-06-09 |
Swiss Skin Repair, Inc. |
Composition
|
|
CA2664944C
(en)
|
2006-09-28 |
2016-06-14 |
Hadasit Medical Research Services & Development Limited |
Use of glycerophospholipids for joint lubrication
|
|
JP4732307B2
(ja)
*
|
2006-11-20 |
2011-07-27 |
株式会社アンズコーポレーション |
ナノエマルション及びそれを配合した化粧料
|
|
US20100130611A1
(en)
|
2006-12-20 |
2010-05-27 |
Cenestra Llc |
Omega 3 fatty acid formulations
|
|
EP1938801A1
(en)
|
2006-12-22 |
2008-07-02 |
Biofrontera Bioscience GmbH |
Nanoemulsion
|
|
US9511016B2
(en)
|
2007-06-12 |
2016-12-06 |
Epicentrx, Inc. |
Topical composition for treating pain
|
|
ITVR20080006A1
(it)
|
2008-01-23 |
2009-07-24 |
David Ceretta |
Apparato per la realizzazione di elementi d'impasto
|
|
ES2335636B1
(es)
|
2008-02-29 |
2011-05-11 |
Lipotec, S.A. |
Composicion cosmetica o dermofarmaceutica de micelas mixtas.
|
|
JP2009256331A
(ja)
|
2008-03-25 |
2009-11-05 |
Nagase Chemtex Corp |
高尿酸血症、又は痛風の予防、改善、又は治療剤
|
|
US20100105139A1
(en)
|
2008-10-27 |
2010-04-29 |
Remco Alexander Spanjaard |
Ligand Targeted Nanocapsules for the delivery of RNAi and other Agents
|
|
KR20110128283A
(ko)
|
2009-02-05 |
2011-11-29 |
타겟티드 딜리버리 테크놀러지스 리미티드 |
미생물체의 증식 및 생존도를 감소시키는 방법
|
|
CN105434353A
(zh)
|
2009-06-03 |
2016-03-30 |
斯昆申技术控股有限责任公司 |
用于治疗深部组织疼痛的制剂
|
|
GB2486371A
(en)
|
2009-08-21 |
2012-06-13 |
Targeted Delivery Technologies Ltd |
Vesicular formulations
|
|
EP2382994A1
(en)
|
2010-04-26 |
2011-11-02 |
Maurizio Victor Cattaneo |
Ligand targeted nanocapsules for the delivery of RNAi and other agents
|
|
WO2011162802A1
(en)
|
2010-06-21 |
2011-12-29 |
Virun, Inc. |
Compositions containing non-polar compounds
|
|
US20120045405A1
(en)
|
2010-08-18 |
2012-02-23 |
Gilman Miles E |
Under eye cream
|
|
GB201206486D0
(en)
|
2012-04-12 |
2012-05-30 |
Sequessome Technology Holdings Ltd |
Vesicular formulations and uses thereof
|
|
GB201208384D0
(en)
|
2012-05-14 |
2012-06-27 |
Sequessome Technology Holdings Ltd |
Vesicular formulations, uses and methods
|
|
GB201208409D0
(en)
|
2012-05-14 |
2012-06-27 |
Sequessome Technology Holdings Ltd |
Vesicular formulations, kits and uses
|
|
AU2014298426B2
(en)
|
2013-07-31 |
2019-07-18 |
Sequessome Technology Holdings Limited |
Vesicles
|